Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman Schmidt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Function of the Th17/interleukin-17A immune response in murine lupus nephritisTilman Schmidt, Hans-Joachim Paust, Christian F Krebs, et al.
Journal of the American Society of Nephrology : JASN|February 28, 2018
IL-17C/IL-17 Receptor E Signaling in CD4<sup>+</sup> T Cells Promotes T<sub>H</sub>17 Cell-Driven Glomerular InflammationSonja Krohn, Jasper F Nies, Sonja Kapffer, et al.
Journal of the American Society of Nephrology : JASN|August 17, 2013
MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GNChristian F Krebs, Sonja Kapffer, Hans-Joachim Paust, et al.
Cells|April 13, 2026
Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKDTim Lange, Luzia Maron, Stefan Simm, et al.
Journal of the American Society of Nephrology : JASN|February 15, 2022
IL-17 Receptor C Signaling Controls CD4<sup>+</sup> T<sub>H</sub>17 Immune Responses and Tissue Injury in Immune-Mediated Kidney DiseasesTilman Schmidt, Jonas Luebbe, Christoph Kilian, et al.
Blood|February 11, 2026
Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic PurpuraLucas Kühne, Thomas Osterholt, Maximilian Suer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Function of the Th17/interleukin-17A immune response in murine lupus nephritisTilman Schmidt, Hans-Joachim Paust, Christian F Krebs, et al.
Journal of the American Society of Nephrology : JASN|February 28, 2018
IL-17C/IL-17 Receptor E Signaling in CD4<sup>+</sup> T Cells Promotes T<sub>H</sub>17 Cell-Driven Glomerular InflammationSonja Krohn, Jasper F Nies, Sonja Kapffer, et al.
Journal of the American Society of Nephrology : JASN|August 17, 2013
MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GNChristian F Krebs, Sonja Kapffer, Hans-Joachim Paust, et al.
Cells|April 13, 2026
Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKDTim Lange, Luzia Maron, Stefan Simm, et al.
Journal of the American Society of Nephrology : JASN|February 15, 2022
IL-17 Receptor C Signaling Controls CD4<sup>+</sup> T<sub>H</sub>17 Immune Responses and Tissue Injury in Immune-Mediated Kidney DiseasesTilman Schmidt, Jonas Luebbe, Christoph Kilian, et al.
Blood|February 11, 2026
Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic PurpuraLucas Kühne, Thomas Osterholt, Maximilian Suer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 2